Skip to main content

Peer Review reports

From: Analysis of antiviral efficacy after switching from brand to generic entecavir in patients with treatment-naïve chronic hepatitis B

Original Submission
24 Dec 2021 Submitted Original manuscript
5 Jan 2022 Author responded Author comments - Chia-Lin Wu
Resubmission - Version 2
5 Jan 2022 Submitted Manuscript version 2
25 Jan 2022 Reviewed Reviewer Report
7 Feb 2022 Reviewed Reviewer Report
23 Feb 2022 Author responded Author comments - Chia-Lin Wu
Resubmission - Version 3
23 Feb 2022 Submitted Manuscript version 3
5 Mar 2022 Author responded Author comments - Chia-Lin Wu
Resubmission - Version 4
5 Mar 2022 Submitted Manuscript version 4
31 Mar 2022 Reviewed Reviewer Report
18 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
4 May 2022 Editorially accepted
10 May 2022 Article published 10.1186/s12876-022-02317-7

You can find further information about peer review here.

Back to article page